The Lymphotoxin-β Receptor Is Necessary and Sufficient for LIGHT-mediated Apoptosis of Tumor Cells*
暂无分享,去创建一个
Chris A. Benedict | Carl F. Ware | C. Benedict | C. Ware | R. Eisenberg | G. Cohen | J. C. Whitbeck | I. Rooney | J. Charles Whitbeck | Gary H. Cohen | Roselyn J. Eisenberg | Isabelle A. Rooney | Kris D. Butrovich | Alison A. Glass | Stephen Borboroglu | A. Glass | K. Butrovich | Stephen Borboroglu | J. Whitbeck | Kristine Butrovich
[1] Y. Goltsev,et al. Tumor necrosis factor receptor and Fas signaling mechanisms. , 1999, Annual review of immunology.
[2] D. Chaplin,et al. Lymphotoxin-α (LTα) Supports Development of Splenic Follicular Structure That Is Required for IgG Responses , 1997, The Journal of experimental medicine.
[3] Peter Scheurich,et al. Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF‐R1 activation by endogenous membrane‐anchored TNF , 1999, The EMBO journal.
[4] A G Porter,et al. Aspartic acid 50 and tyrosine 108 are essential for receptor binding and cytotoxic activity of tumour necrosis factor beta (lymphotoxin). , 1991, Protein engineering.
[5] C. Ware,et al. Expression of the lymphotoxin β receptor on follicular stromal cells in human lymphoid tissues , 1998, Cell Death and Differentiation.
[6] D. Goeddel,et al. TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40 , 1995, Science.
[7] Seamus J. Martin,et al. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas , 1995, Nature.
[8] M. Zafari,et al. Characterization of surface lymphotoxin forms. Use of specific monoclonal antibodies and soluble receptors. , 1995, Journal of immunology.
[9] Jian Ni,et al. A Newly Identified Member of Tumor Necrosis Factor Receptor Superfamily (TR6) Suppresses LIGHT-mediated Apoptosis* , 1999, The Journal of Biological Chemistry.
[10] C. Smith,et al. Activation of the lymphotoxin beta receptor by cross-linking induces chemokine production and growth arrest in A375 melanoma cells. , 1997, Journal of immunology.
[11] J. Tschopp,et al. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB. , 1997, Immunity.
[12] Carl F. Ware,et al. Lymphotoxin β, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface , 1993, Cell.
[13] Mike Rothe,et al. Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor , 1993, Cell.
[14] K. Pfeffer,et al. The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. , 1998, Immunity.
[15] Soo-Young Lee,et al. T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors , 1996, The Journal of experimental medicine.
[16] C. Ambrose,et al. Preparation and Characterization of Soluble Recombinant Heterotrimeric Complexes of Human Lymphotoxins and (*) , 1996, The Journal of Biological Chemistry.
[17] S. Nagata,et al. A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. , 1993, The Journal of biological chemistry.
[18] R. Flavell,et al. Distinct Roles in Lymphoid Organogenesis for Lymphotoxins α and β Revealed in Lymphotoxin β–Deficient Mice , 1997 .
[19] T. Ayres,et al. Herpesvirus Entry Mediator, a Member of the Tumor Necrosis Factor Receptor (TNFR) Family, Interacts with Members of the TNFR-associated Factor Family and Activates the Transcription Factors NF-κB and AP-1* , 1997, The Journal of Biological Chemistry.
[20] H. Mcdevitt,et al. Disrupted splenic architecture, but normal lymph node development in mice expressing a soluble lymphotoxin-beta receptor-IgG1 fusion protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[21] C. Ware,et al. Expression of lymphotoxins and their receptor-Fc fusion proteins by baculovirus. , 2000, Methods in enzymology.
[22] K. Rajewsky,et al. Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[23] D. Botstein,et al. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer , 1998, Nature.
[24] C. Ware,et al. A lymphotoxin-beta-specific receptor. , 1994, Science.
[25] D. Chaplin,et al. Development and maturation of secondary lymphoid tissues. , 1999, Annual review of immunology.
[26] C. Ware,et al. TRAF5, an Activator of NF-κB and Putative Signal Transducer for the Lymphotoxin-β Receptor* , 1996, The Journal of Biological Chemistry.
[27] E. Kieff,et al. Lymphotoxin-β receptor signaling complex: Role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor κB , 1997 .
[28] C. Ware,et al. TNF receptor signal transduction. Ligand-dependent stimulation of a serine protein kinase activity associated with (CD120a) TNFR60. , 1994, Journal of Immunology.
[29] Scott F. Smith,et al. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. , 1994, Science.
[30] C. Thompson,et al. Tumor necrosis factor receptor-associated factors (TRAFs)--a family of adapter proteins that regulates life and death. , 1998, Genes & development.
[31] C. Ware,et al. Production of lymphotoxin (LT alpha) and a soluble dimeric form of its receptor using the baculovirus expression system. , 1994, Journal of immunological methods.
[32] C. Benedict,et al. Discrete Signaling Regions in the Lymphotoxin-β Receptor for Tumor Necrosis Factor Receptor-associated Factor Binding, Subcellular Localization, and Activation of Cell Death and NF-κB Pathways* , 2000, The Journal of Biological Chemistry.
[33] B. Kwon,et al. LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer. , 1998, The Journal of clinical investigation.
[34] Terry Farrah,et al. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death , 1994, Cell.
[35] David D. Chaplin,et al. Role of Lymphotoxin and the Type I TNF Receptor in the Formation of Germinal Centers , 1996, Science.
[36] S. Hsieh,et al. The Cytoplasmic Domain of the Lymphotoxin-β Receptor Mediates Cell Death in HeLa Cells* , 1999, The Journal of Biological Chemistry.
[37] Alan G. Porter,et al. The Lymphotoxin-α (LTα) Subunit Is Essential for the Assembly, but Not for the Receptor Specificity, of the Membrane-anchored LTα1β2 Heterotrimeric Ligand* , 1997, The Journal of Biological Chemistry.
[38] N. Guex,et al. SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling , 1997, Electrophoresis.
[39] M. Zafari,et al. Signaling through the lymphotoxin beta receptor induces the death of some adenocarcinoma tumor lines , 1996, The Journal of experimental medicine.
[40] V. Godfrey,et al. Lymphotoxin-alpha-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness. , 1995, Journal of immunology.
[41] N. Copeland,et al. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF , 1993, Cell.
[42] C. Ware,et al. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. , 1998, Immunity.
[43] C. Ware,et al. The ligands and receptors of the lymphotoxin system. , 1995, Current topics in microbiology and immunology.
[44] T. Deerinck,et al. The IKKβ Subunit of IκB Kinase (IKK) is Essential for Nuclear Factor κB Activation and Prevention of Apoptosis , 1999, The Journal of experimental medicine.
[45] W. J. Boyle,et al. ATAR, a Novel Tumor Necrosis Factor Receptor Family Member, Signals through TRAF2 and TRAF5* , 1997, The Journal of Biological Chemistry.
[46] George Kollias,et al. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor , 1995, Cell.
[47] C. Ware,et al. Dominant Negative Mutants of TRAF3 Reveal an Important Role for the Coiled Coil Domains in Cell Death Signaling by the Lymphotoxin-β Receptor* , 1997, The Journal of Biological Chemistry.
[48] K. Pfeffer,et al. Defective Peyer's patch organogenesis in mice lacking the 55-kD receptor for tumor necrosis factor , 1996, The Journal of experimental medicine.
[49] P. Young,et al. Herpesvirus Entry Mediator Ligand (HVEM-L), a Novel Ligand for HVEM/TR2, Stimulates Proliferation of T Cells and Inhibits HT29 Cell Growth* , 1998, The Journal of Biological Chemistry.